phenylephrine hydrochloride 0.667 MG/ML / thonzylamine hydrochloride 3.33 MG/ML Oral Solution [Nasopen PE]
RxNorm concept 1360733, branded drug (sbd). Prescribable name: NASOPEN PE 10 MG / 50 MG in 15 mL Oral Solution.
- RxCUI
- 1360733
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1360733 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Nasopen PE (phenylephrine HCl 10 MG / thonzylamine HCl 50 MG) per 15 ML Oral Solution
Related concepts
- phenylephrine hydrochloride 0.667 MG/ML (SCDC, consists of)
- thonzylamine hydrochloride 3.33 MG/ML (SCDC, consists of)
- phenylephrine hydrochloride 0.667 MG/ML / thonzylamine hydrochloride 3.33 MG/ML [Nasopen PE] (SBDC, consists of)
- Oral Solution (DF, has dose form)
- Nasopen PE (BN, has ingredient)
- phenylephrine hydrochloride 0.667 MG/ML / thonzylamine hydrochloride 3.33 MG/ML Oral Solution (SCD, tradename of)
Linked data
NDCs
- 58809072904
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1360733 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1360733 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1360733. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.